sulofenur has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberts, DS; Grindey, GB; Hamilton, M; Matzner, M; McCloskey, TM; Peng, YM; Plezia, PM; Roe, DJ; Seitz, D; Taylor, CW | 1 |
| Hardy, J; Hatty, S; O'Brien, ME; Peters, B; Tan, S; Walling, J; Wiltshaw, E | 1 |
2 trial(s) available for sulofenur and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Carcinoma; Drug Administration Schedule; Female; Humans; Methemoglobinemia; Middle Aged; Ovarian Neoplasms; Sulfonylurea Compounds | 1992 |
A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma; Cisplatin; Drug Evaluation; Drug Resistance; Female; Humans; Middle Aged; Ovarian Neoplasms; Recurrence; Sulfonylurea Compounds | 1992 |